Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportClinical Science

Total-body 18F-FDG PET Evaluation of Lymphoid Tissues Post Myocardial Infarction

Kwame Atsina, Eliseo Vazquez, Elizabeth Cortez-Toledo, Elizabeth Li, Yasser Abdelhafez, Guobao Wang, Saul Schaefer, Simon Cherry and Javier López
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3392;
Kwame Atsina
1UC Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliseo Vazquez
2Rush Medical College
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Cortez-Toledo
3University of California Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Li
3University of California Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasser Abdelhafez
3University of California Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guobao Wang
4University of California - Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saul Schaefer
3University of California Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Cherry
5University of California at Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier López
1UC Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

3392

Introduction: Activation of extra-cardiac immune cells and organs like the spleen and bone marrow has been demonstrated after acute myocardial infarction (AMI). This extra-cardiac response may play a role in recovery after AMI and, thus, characterizing its activation may lay the groundwork for novel therapies that directly target immune cells or organs. A novel high-sensitivity high spatial-resolution molecular imaging modality, the EXPLORER PET/CT, can provide high resolution 3-dimensional imaging of the entire human body in a single scan, permitting the assessment of the multi-organ inflammatory response to AMI. Using 18F-FDG total-body PET/CT, our study examined the metabolic activity of multiple lymphoid tissues simultaneously, particularly the bone marrow, spleen, and regional lymph nodes (LNs), in subjects after AMI compared to healthy controls.

Methods: Ten subjects who were treated for AMI with percutaneous coronary intervention (PCI) and guideline-directed medical therapy were evaluated with static total-body 18F-FDG PET/CT after 7-12 days of initial presentation and compared to 15 controls. Analysis of standardized uptake value (SUV) in the regional LNs, spleen, and bone marrow, was performed to assess multi-organ metabolic activity; static PET images were acquired 90-110 minutes post-injection, using AMIDE software. The LNs were categorized into 3 broad regions - head and neck, axillary and inguinal. The bone marrow was represented by the first to fifth lumbar vertebrae. The mean 18F-FDG dose administered to the control group was 10.1 ± 0.5 mCi, compared to 5.2 ± 0.2 mCi in the AMI group. This difference was adjusted for during PET analysis.

Results: The mean age, sex, weight, and fasting blood glucose levels were not significantly different between the AMI and control groups. As shown in Table 1 and Figure 1, the SUVmax in the LNs was increased by 1.9-fold in the right and 2.3-fold in the left head and neck regions, 2.1-fold in the right and 2.3-fold in the left axillary regions, and 2.8-fold in the right and 2.2-fold in the left inguinal regions in AMI subjects compared to controls. Additionally, the SUVmax was increased by 1.3-fold in the bone marrow and 1.5-fold in the spleen in AMI subjects compared to controls.

Conclusions: This study evaluated the metabolic activity of three extra-cardiac lymphoid organs simultaneously in subjects after AMI using a total-body 18F-FDG PET/CT. In addition to increased metabolic activity in the bone marrow and spleen, shown in previous studies, we found that subjects with AMI had significantly increased metabolic activity in the head and neck, axillary and inguinal lymph nodes. Seven out of the 10 AMI patients received PCI via the right femoral artery, possibly accounting for the higher signal noted on the right inguinal region. Additional studies are needed to further characterize this multi-organ lymphoid activation and the risk of future adverse cardiovascular events post AMI.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Total-body 18F-FDG PET Evaluation of Lymphoid Tissues Post Myocardial Infarction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Total-body 18F-FDG PET Evaluation of Lymphoid Tissues Post Myocardial Infarction
Kwame Atsina, Eliseo Vazquez, Elizabeth Cortez-Toledo, Elizabeth Li, Yasser Abdelhafez, Guobao Wang, Saul Schaefer, Simon Cherry, Javier López
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3392;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Total-body 18F-FDG PET Evaluation of Lymphoid Tissues Post Myocardial Infarction
Kwame Atsina, Eliseo Vazquez, Elizabeth Cortez-Toledo, Elizabeth Li, Yasser Abdelhafez, Guobao Wang, Saul Schaefer, Simon Cherry, Javier López
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3392;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Development and External Validation of Ischemia Risk Scores
  • 99mTc-pyrophosphate right ventricular myocardial uptake in ATTR
Show more Clinical Science

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire